 is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Xeloda belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying.This medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal.Common side effects include diarrhea, nausea, vomiting, and mouth sores. "Pin It")
Xeloda Overview
Xeloda (generic: capecitabine) is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Xeloda belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying.
This medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal.
Common side effects include diarrhea, nausea, vomiting, and mouth sores.
Uses of Xeloda
Xeloda is a prescription medication used to treat:
- cancer of the colon after surgery
- cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic colorectal cancer).
- breast cancer that has spread to other parts of the body (metastatic breast cancer) together with another medicine called docetaxel (Taxotere)
- breast cancer that has spread to other parts of the body and has not improved after treatment with other medicines such as paclitaxel (Taxol) and anthracycline-containing medicine such as Adriamycin and doxorubicin.
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.
Side Effects of Xeloda
The most common side effects of Xeloda are:
- diarrhea, nausea, vomiting, sores in the mouth and throat (stomatitis), stomach area pain (abdominal pain), upset stomach, constipation, loss of appetite, and too much water loss from the body (dehydration). These side effects are more common in patients age 80 and older.
- hand-and-foot syndrome (palms of the hands or soles of the feet tingle, become numb, painful, swollen or red), rash, dry, itchy or discolored skin, nail problems, and hair loss
- tiredness, weakness, dizziness, headache, fever, pain (including chest, back, joint, and muscle pain), trouble sleeping, and taste problems These side effects may differ when taking Xeloda with docetaxel (Taxotere). Please consult your doctor for possible side effects that may be caused by taking Xeloda with docetaxel (Taxotere).
- Diarrhea: Tell your doctor if you have an additional 4 bowel movements each day beyond what is normal or any diarrhea at night
- Vomiting: Tell your doctor if you vomit more than once in a 24-hour time period
- Nausea: Tell your doctor if you lose your appetite, and the amount of food you eat each day is much less than usual
- Stomatitis: Tell your doctor if you have pain, redness, swelling or sores in your mouth
- Hand-and-Foot Syndrome: Tell your doctor if you have pain, swelling or redness of your hands or feet that prevents normal activity
- Fever or Infection: Tell your doctor if you have a temperature of 100.5°F or greater, or other signs of infection Your doctor may tell you to lower the dose or to stop Xeloda treatment for a while. If caught early, most of these side effects usually improve after you stop taking Xeloda. If they do not improve within 2 to 3 days, call your doctor again. After your side effects have improved, your doctor will tell you whether to start taking Xeloda again and what dose to take. Adjusting the dose of Xeloda to be right for each patient is an important part of treatment.
Xeloda Interactions
Xeloda may increase the effect of other medicines used to thin your blood such as warfarin (Coumadin). It is very important that your doctor knows if you are taking a blood thinner such as warfarin because Xeloda may increase the effect of this medicine and could lead to serious side effects. If you are taking blood thinners and Xeloda, your doctor needs to check more often how fast your blood clots and change the dose of the blood thinner, if needed.
If you take phenytoin (Dilantin), your doctor may need to test the levels of phenytoin in your blood more often or change your dose of phenytoin.
Xeloda Precautions
DO NOT TAKE XELODA IF YOU
- are nursing a baby. Tell your doctor if you are nursing. Xeloda may pass to the baby in your milk and harm the baby.
- are allergic to 5-fluorouracil
- are allergic to capecitabine or to any of the ingredients in Xeloda
- have been told that you lack the enzyme DPD (dihydropyrimidine dehydrogenase)
Xeloda Food Interactions
Medicines can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Xeloda there are no specific foods that you must exclude from your diet when receiving Xeloda.
Inform MD
TELL YOUR DOCTOR IF YOU
- take a blood thinner such as warfarin (Coumadin). This is very important because Xeloda may increase the effect of the blood thinner. If you are taking blood thinners and Xeloda, your doctor needs to check more often how fast your blood clots and change the dose of the blood thinner, if needed.
- take phenytoin (Dilantin). Your doctor needs to test the levels of phenytoin in your blood more often or change your dose of phenytoin.
- are pregnant or think you may be pregnant. Xeloda may harm your unborn child.
- have kidney problems. Your doctor may prescribe a different medicine or lower the Xeloda dose.
- have liver problems. You may need to be checked for liver problems while you take Xeloda.
- have heart problems because you could have more side effects related to your heart.
- take the vitamin folic acid. It may affect how Xeloda works.
Xeloda and Pregnancy
Tell your doctor if you are pregnant or think you may be pregnant. Xeloda may harm your unborn child.
Xeloda and Lactation
Tell your doctor if you are breastfeeding or plan to breastfeed. It is not known if Xeloda is excreted in human breast milk or if it will harm your nursing baby.
Xeloda Usage
- Take Xeloda exactly as your doctor tells you to. Your doctor will prescribe a dose and treatment plan that is right for you. Your doctor may want you to take both 150 mg and 500 mg tablets together for each dose. If so, you must be able to identify the tablets. Taking the wrong tablets could cause an overdose (too much medicine) or underdose (too little medicine). The 150 mg tablets are light peach in color with 150 on one side. The 500 mg tablets are peach in color with 500 on one side. Your doctor may change the amount of medicine you take during your treatment. Your doctor may prescribe Xeloda Tablets with docetaxel (Taxotere) injection.
- Xeloda is taken in 2 daily doses, a morning dose and an evening dose
- Take Xeloda tablets within 30 minutes after the end of a meal (breakfast and dinner)
- Swallow Xeloda tablets whole with water
- If you miss a dose of Xeloda, do not take the missed dose at all and do not double the next dose. Instead, continue your regular dosing schedule and check with your doctor.
- Xeloda is usually taken for 14 days followed by a 7-day rest period (no drug), for a 21-day cycle. Your doctor will tell you how many cycles of treatment you will need.
- If you take too much Xeloda, contact your doctor or local poison control center or emergency room right away. What should I avoid while taking Xeloda?
- Women should not become pregnant while taking Xeloda. Xeloda may harm your unborn child. Use effective birth control while taking Xeloda. Tell your doctor if you become pregnant.
- Do not breast-feed. Xeloda may pass through your milk and harm your baby.
- Men should use birth control while taking Xeloda
Xeloda Dosage
Take Xeloda exactly as prescribed by your doctor. Follow the directions on your prescription label carefully. Your doctor will determine the best dose for you.
Standard Starting Dose
Monotherapy (Metastatic Colorectal Cancer, Adjuvant Colorectal Cancer, Metastatic Breast Cancer)
The recommended dose of Xeloda is 1250 mg/m2 administered orally twice daily (morning and evening; equivalent to 2500 mg/m2 total daily dose) for 2 weeks followed by a 1-week rest period given as 3-week cycles.
Adjuvant treatment in patients with Dukes' C colon cancer is recommended for a total of 6 months [ie, Xeloda 1250 mg/m2 orally twice daily for 2 weeks followed by a 1-week rest period, given as 3-week cycles for a total of 8 cycles (24 weeks)].
In Combination With Docetaxel (Metastatic Breast Cancer)
In combination with docetaxel, the recommended dose of Xeloda is 1250 mg/m2 twice daily for 2 weeks followed by a 1-week rest period, combined with docetaxel at 75 mg/m2 as a 1-hour intravenous infusion every 3 weeks. Pre-medication, according to the docetaxel labeling, should be started prior to docetaxel administration for patients receiving the Xeloda plus docetaxel combination.
Xeloda dosage may need to be individualized to optimize patient management. Patients should be carefully monitored for toxicity and doses of Xeloda should be modified as necessary to accommodate individual patient tolerance to treatment
Xeloda Overdose
If you take too much Xeloda, call your local Poison Control Center or seek emergency medical attention right away.
Forms of Xeloda
Xeloda tables are available in the following strengths: 150 mg, and 500 mg.
Active ingredient: capecitabine
Inactive ingredients: croscarmellose sodium, hypromellose 2208 (15000 MPA S), microcrystalline cellulose, magnesium stearate, water, talc, titanium dioxide, ferric oxide red, ferric oxide yellow.
Other Requirements
- Never share Xeloda with anyone
- Store Xeloda at normal room temperature (about 65° to 85°F)
- Keep Xeloda and all other medicines out of the reach of children
Xeloda FDA Warning
WARNING: XELODA-WARFARIN INTERACTION
Xeloda Warfarin Interaction: Patients receiving concomitant capecitabine and oral coumarin-derivative anticoagulant therapy should have their anticoagulant response (INR or prothrombin time) monitored frequently in order to adjust the anticoagulant dose accordingly. A clinically important Xeloda-Warfarin drug interaction was demonstrated in a clinical pharmacology trial. Altered coagulation parameters and/or bleeding, including death, have been reported in patients taking Xeloda concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon. Postmarketing reports have shown clinically significant increases in prothrombin time (PT) and INR in patients who were stabilized on anticoagulants at the time Xeloda was introduced. These events occurred within several days and up to several months after initiating Xeloda therapy and, in a few cases, within 1 month after stopping Xeloda. These events occurred in patients with and without liver metastases. Age greater than 60 and a diagnosis of cancer independently predispose patients to an increased risk of coagulopathy.
